STOCK TITAN

[Form 4] Zimmer Biomet Holdings, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

OCI N.V. and its Dutch subsidiaries OCI Intermediate B.V. and OCI Chemicals B.V. have filed a Schedule 13G disclosing a sizeable passive stake in Methanex Corporation (NASDAQ/TSX: MEOH). The filing, triggered by a June 27 2025 event date, shows beneficial ownership of 9,944,308 common shares, equal to 12.9 % of Methanex’s 77,339,520 shares outstanding as of June 30 2025.

All shares are held with shared voting power over 7,726,218 shares – subject to an undertaking not to vote more than 9.99 % of the company’s outstanding stock until Toronto Stock Exchange listing conditions are satisfied – and shared dispositive power over the full 9.94 million-share position. The reporting persons possess no sole voting or dispositive authority, underscoring the filing’s passive intent. Each entity certifies that the securities were not acquired for the purpose of influencing control, in line with Schedule 13G requirements.

The disclosure makes OCI – a Netherlands-based global producer of nitrogen, methanol and hydrogen products – one of Methanex’s largest known shareholders. While the filing does not announce any transaction terms or strategic plans, the scale of the stake (worth roughly US$450-500 million at recent prices) signals institutional confidence in Methanex’s methanol market outlook and could foreshadow future collaboration or corporate activity within the global methanol value chain.

OCI N.V. e le sue controllate olandesi OCI Intermediate B.V. e OCI Chemicals B.V. hanno presentato un Schedule 13G, rivelando una significativa partecipazione passiva in Methanex Corporation (NASDAQ/TSX: MEOH). La comunicazione, relativa a un evento del 27 giugno 2025, indica una proprietà effettiva di 9.944.308 azioni ordinarie, pari al 12,9% delle 77.339.520 azioni in circolazione di Methanex al 30 giugno 2025.

Tutte le azioni sono detenute con potere di voto condiviso su 7.726.218 azioni – soggetto a un impegno a non votare più del 9,99% del capitale sociale fino al soddisfacimento delle condizioni per la quotazione alla Borsa di Toronto – e potere dispositive condiviso sull’intera posizione di 9,94 milioni di azioni. I soggetti segnalanti non detengono autorità esclusiva di voto o dispositiva, sottolineando la natura passiva della comunicazione. Ogni entità certifica che i titoli non sono stati acquisiti con l’intento di influenzare il controllo, in conformità ai requisiti dello Schedule 13G.

La comunicazione rende OCI – produttore globale con sede nei Paesi Bassi di prodotti a base di azoto, metanolo e idrogeno – uno dei maggiori azionisti noti di Methanex. Sebbene la comunicazione non annunci termini di transazioni o piani strategici, l’entità della partecipazione (del valore approssimativo di 450-500 milioni di dollari USA ai prezzi recenti) segnala fiducia istituzionale nelle prospettive di mercato del metanolo di Methanex e potrebbe preannunciare future collaborazioni o attività societarie nella catena del valore globale del metanolo.

OCI N.V. y sus filiales holandesas OCI Intermediate B.V. y OCI Chemicals B.V. han presentado un Schedule 13G revelando una participación pasiva considerable en Methanex Corporation (NASDAQ/TSX: MEOH). La presentación, originada por un evento del 27 de junio de 2025, muestra una propiedad beneficiaria de 9,944,308 acciones comunes, equivalentes al 12.9% de las 77,339,520 acciones en circulación de Methanex al 30 de junio de 2025.

Todas las acciones se mantienen con poder de voto compartido sobre 7,726,218 acciones – sujeto a un compromiso de no votar más del 9.99% del capital social hasta que se cumplan las condiciones para la cotización en la Bolsa de Valores de Toronto – y poder dispositvo compartido sobre la posición total de 9.94 millones de acciones. Las personas que reportan no poseen autoridad exclusiva de voto o dispositiva, destacando la intención pasiva de la presentación. Cada entidad certifica que los valores no fueron adquiridos con el propósito de influir en el control, conforme a los requisitos del Schedule 13G.

La divulgación convierte a OCI – un productor global con sede en los Países Bajos de productos de nitrógeno, metanol e hidrógeno – en uno de los mayores accionistas conocidos de Methanex. Aunque la presentación no anuncia términos de transacción ni planes estratégicos, la magnitud de la participación (valorada en aproximadamente 450-500 millones de dólares estadounidenses a precios recientes) señala confianza institucional en las perspectivas del mercado del metanol de Methanex y podría anticipar futuras colaboraciones o actividades corporativas dentro de la cadena de valor global del metanol.

OCI N.V.와 그 네덜란드 자회사인 OCI Intermediate B.V. 및 OCI Chemicals B.V.가 Methanex Corporation (NASDAQ/TSX: MEOH)에 대한 상당한 수동적 지분을 공개하는 Schedule 13G를 제출했습니다. 2025년 6월 27일 이벤트를 계기로 제출된 이 문서는 2025년 6월 30일 기준 Methanex의 발행 주식 77,339,520주 중 12.9%에 해당하는 9,944,308주의 실질 소유권을 보유하고 있음을 보여줍니다.

모든 주식은 7,726,218주에 대한 공동 의결권을 가지고 있으며 – 토론토 증권거래소 상장 조건이 충족될 때까지 회사 발행 주식의 9.99%를 초과하여 투표하지 않겠다는 약속이 있습니다 – 그리고 전체 994만 주 포지션에 대한 공동 처분 권한을 보유하고 있습니다. 보고자는 단독 의결권이나 처분 권한을 갖고 있지 않으며, 이는 제출 문서의 수동적 의도를 강조합니다. 각 기관은 증권이 Schedule 13G 요건에 따라 지배권에 영향을 미치기 위해 취득된 것이 아님을 인증합니다.

이번 공개로 인해 네덜란드에 본사를 둔 질소, 메탄올 및 수소 제품의 글로벌 생산업체인 OCI는 Methanex의 가장 큰 알려진 주주 중 하나가 되었습니다. 제출 문서에는 거래 조건이나 전략적 계획이 명시되어 있지 않지만, 최근 가격 기준 약 4억 5천만~5억 달러 상당의 지분 규모는 Methanex의 메탄올 시장 전망에 대한 기관 투자자의 신뢰를 나타내며, 향후 글로벌 메탄올 가치 사슬 내 협력 또는 기업 활동을 예고할 수 있습니다.

OCI N.V. et ses filiales néerlandaises OCI Intermediate B.V. et OCI Chemicals B.V. ont déposé un Schedule 13G révélant une participation passive importante dans Methanex Corporation (NASDAQ/TSX : MEOH). Le dépôt, déclenché par un événement daté du 27 juin 2025, indique une possession bénéficiaire de 9 944 308 actions ordinaires, soit 12,9 % des 77 339 520 actions en circulation de Methanex au 30 juin 2025.

Toutes les actions sont détenues avec un pouvoir de vote partagé sur 7 726 218 actions – soumis à un engagement de ne pas voter plus de 9,99 % des actions en circulation de la société tant que les conditions d'inscription à la Bourse de Toronto ne sont pas remplies – et un pouvoir discrétionnaire partagé sur l'intégralité de la position de 9,94 millions d'actions. Les personnes déclarantes ne détiennent aucune autorité exclusive de vote ou de disposition, soulignant l'intention passive du dépôt. Chaque entité certifie que les titres n'ont pas été acquis dans le but d'influencer le contrôle, conformément aux exigences du Schedule 13G.

Cette divulgation fait d'OCI – un producteur mondial basé aux Pays-Bas de produits à base d'azote, de méthanol et d'hydrogène – l'un des plus grands actionnaires connus de Methanex. Bien que le dépôt n'annonce aucune condition de transaction ni plan stratégique, l'ampleur de la participation (d'une valeur d'environ 450 à 500 millions de dollars américains aux prix récents) témoigne de la confiance institutionnelle dans les perspectives du marché du méthanol de Methanex et pourrait présager une future collaboration ou activité d'entreprise au sein de la chaîne de valeur mondiale du méthanol.

OCI N.V. und seine niederländischen Tochtergesellschaften OCI Intermediate B.V. und OCI Chemicals B.V. haben ein Schedule 13G eingereicht, das eine beträchtliche passive Beteiligung an der Methanex Corporation (NASDAQ/TSX: MEOH) offenlegt. Die Meldung, ausgelöst durch ein Ereignis am 27. Juni 2025, zeigt eine wirtschaftliche Eigentümerschaft von 9.944.308 Stammaktien, was 12,9 % der 77.339.520 ausstehenden Methanex-Aktien zum 30. Juni 2025 entspricht.

Alle Aktien werden mit gemeinsamem Stimmrecht über 7.726.218 Aktien gehalten – unter der Auflage, nicht mehr als 9,99 % der ausstehenden Aktien des Unternehmens zu stimmen, bis die Bedingungen für die Notierung an der Toronto Stock Exchange erfüllt sind – und mit gemeinsamem Verfügungsrecht über die gesamte Position von 9,94 Millionen Aktien. Die meldenden Personen besitzen keine alleinige Stimm- oder Verfügungsbefugnis, was die passive Absicht der Meldung unterstreicht. Jede Einheit bestätigt, dass die Wertpapiere nicht zum Zweck der Einflussnahme auf die Kontrolle erworben wurden, gemäß den Anforderungen des Schedule 13G.

Die Offenlegung macht OCI – einen globalen Produzenten von Stickstoff-, Methanol- und Wasserstoffprodukten mit Sitz in den Niederlanden – zu einem der größten bekannten Aktionäre von Methanex. Obwohl die Meldung keine Transaktionsbedingungen oder strategischen Pläne bekannt gibt, signalisiert der Umfang der Beteiligung (im Wert von etwa 450-500 Millionen US-Dollar zu den jüngsten Kursen) institutionelles Vertrauen in die Methanolmarktprognosen von Methanex und könnte auf zukünftige Kooperationen oder Unternehmensaktivitäten innerhalb der globalen Methanol-Wertschöpfungskette hinweisen.

Positive
  • OCI acquires a 12.9 % economic interest, signaling institutional confidence in Methanex’s business and potentially strengthening the shareholder base.
  • Block ownership reduces free-float supply, which can offer near-term support to Methanex’s share price.
  • Strategic industry alignment between OCI and Methanex could open the door to collaborations or future corporate actions.
Negative
  • Potential overhang risk exists if OCI later decides to divest its sizable position, which could pressure the stock.
  • Voting power capped at 9.99 %, limiting any immediate governance influence while still raising questions about longer-term intentions.

Insights

TL;DR – OCI reveals a 12.9 % passive stake in Methanex, indicating strategic interest and potential industry alignment.

The 9.9 million-share position makes OCI one of Methanex’s largest shareholders, representing c. US$0.5 bn. Although filed on Schedule 13G (passive intent), OCI’s core business—methanol and hydrogen derivatives—closely overlaps Methanex’s. Large cross-industry stakes often precede joint ventures, board representation requests or, in the longer term, control transactions. Even without activism, the holding removes a sizeable free-float block and may support the share price. The voting cap to 9.99 % suggests OCI is complying with TSX rules while still maintaining economic exposure. Overall, the news is incrementally positive for sentiment and may fuel speculation about strategic options.

TL;DR – Filing is neutral from a governance perspective; stake is large but expressly passive.

Schedule 13G indicates OCI has no current intent to influence control, and the certification language reinforces that stance. The absence of sole voting rights and the self-imposed 9.99 % voting cap further limit governance impact. Methanex’s existing board and management retain full control. Investors should monitor future filings; a switch to Schedule 13D would mark a material shift. For now, governance risk is low, and the disclosure mainly enhances transparency.

OCI N.V. e le sue controllate olandesi OCI Intermediate B.V. e OCI Chemicals B.V. hanno presentato un Schedule 13G, rivelando una significativa partecipazione passiva in Methanex Corporation (NASDAQ/TSX: MEOH). La comunicazione, relativa a un evento del 27 giugno 2025, indica una proprietà effettiva di 9.944.308 azioni ordinarie, pari al 12,9% delle 77.339.520 azioni in circolazione di Methanex al 30 giugno 2025.

Tutte le azioni sono detenute con potere di voto condiviso su 7.726.218 azioni – soggetto a un impegno a non votare più del 9,99% del capitale sociale fino al soddisfacimento delle condizioni per la quotazione alla Borsa di Toronto – e potere dispositive condiviso sull’intera posizione di 9,94 milioni di azioni. I soggetti segnalanti non detengono autorità esclusiva di voto o dispositiva, sottolineando la natura passiva della comunicazione. Ogni entità certifica che i titoli non sono stati acquisiti con l’intento di influenzare il controllo, in conformità ai requisiti dello Schedule 13G.

La comunicazione rende OCI – produttore globale con sede nei Paesi Bassi di prodotti a base di azoto, metanolo e idrogeno – uno dei maggiori azionisti noti di Methanex. Sebbene la comunicazione non annunci termini di transazioni o piani strategici, l’entità della partecipazione (del valore approssimativo di 450-500 milioni di dollari USA ai prezzi recenti) segnala fiducia istituzionale nelle prospettive di mercato del metanolo di Methanex e potrebbe preannunciare future collaborazioni o attività societarie nella catena del valore globale del metanolo.

OCI N.V. y sus filiales holandesas OCI Intermediate B.V. y OCI Chemicals B.V. han presentado un Schedule 13G revelando una participación pasiva considerable en Methanex Corporation (NASDAQ/TSX: MEOH). La presentación, originada por un evento del 27 de junio de 2025, muestra una propiedad beneficiaria de 9,944,308 acciones comunes, equivalentes al 12.9% de las 77,339,520 acciones en circulación de Methanex al 30 de junio de 2025.

Todas las acciones se mantienen con poder de voto compartido sobre 7,726,218 acciones – sujeto a un compromiso de no votar más del 9.99% del capital social hasta que se cumplan las condiciones para la cotización en la Bolsa de Valores de Toronto – y poder dispositvo compartido sobre la posición total de 9.94 millones de acciones. Las personas que reportan no poseen autoridad exclusiva de voto o dispositiva, destacando la intención pasiva de la presentación. Cada entidad certifica que los valores no fueron adquiridos con el propósito de influir en el control, conforme a los requisitos del Schedule 13G.

La divulgación convierte a OCI – un productor global con sede en los Países Bajos de productos de nitrógeno, metanol e hidrógeno – en uno de los mayores accionistas conocidos de Methanex. Aunque la presentación no anuncia términos de transacción ni planes estratégicos, la magnitud de la participación (valorada en aproximadamente 450-500 millones de dólares estadounidenses a precios recientes) señala confianza institucional en las perspectivas del mercado del metanol de Methanex y podría anticipar futuras colaboraciones o actividades corporativas dentro de la cadena de valor global del metanol.

OCI N.V.와 그 네덜란드 자회사인 OCI Intermediate B.V. 및 OCI Chemicals B.V.가 Methanex Corporation (NASDAQ/TSX: MEOH)에 대한 상당한 수동적 지분을 공개하는 Schedule 13G를 제출했습니다. 2025년 6월 27일 이벤트를 계기로 제출된 이 문서는 2025년 6월 30일 기준 Methanex의 발행 주식 77,339,520주 중 12.9%에 해당하는 9,944,308주의 실질 소유권을 보유하고 있음을 보여줍니다.

모든 주식은 7,726,218주에 대한 공동 의결권을 가지고 있으며 – 토론토 증권거래소 상장 조건이 충족될 때까지 회사 발행 주식의 9.99%를 초과하여 투표하지 않겠다는 약속이 있습니다 – 그리고 전체 994만 주 포지션에 대한 공동 처분 권한을 보유하고 있습니다. 보고자는 단독 의결권이나 처분 권한을 갖고 있지 않으며, 이는 제출 문서의 수동적 의도를 강조합니다. 각 기관은 증권이 Schedule 13G 요건에 따라 지배권에 영향을 미치기 위해 취득된 것이 아님을 인증합니다.

이번 공개로 인해 네덜란드에 본사를 둔 질소, 메탄올 및 수소 제품의 글로벌 생산업체인 OCI는 Methanex의 가장 큰 알려진 주주 중 하나가 되었습니다. 제출 문서에는 거래 조건이나 전략적 계획이 명시되어 있지 않지만, 최근 가격 기준 약 4억 5천만~5억 달러 상당의 지분 규모는 Methanex의 메탄올 시장 전망에 대한 기관 투자자의 신뢰를 나타내며, 향후 글로벌 메탄올 가치 사슬 내 협력 또는 기업 활동을 예고할 수 있습니다.

OCI N.V. et ses filiales néerlandaises OCI Intermediate B.V. et OCI Chemicals B.V. ont déposé un Schedule 13G révélant une participation passive importante dans Methanex Corporation (NASDAQ/TSX : MEOH). Le dépôt, déclenché par un événement daté du 27 juin 2025, indique une possession bénéficiaire de 9 944 308 actions ordinaires, soit 12,9 % des 77 339 520 actions en circulation de Methanex au 30 juin 2025.

Toutes les actions sont détenues avec un pouvoir de vote partagé sur 7 726 218 actions – soumis à un engagement de ne pas voter plus de 9,99 % des actions en circulation de la société tant que les conditions d'inscription à la Bourse de Toronto ne sont pas remplies – et un pouvoir discrétionnaire partagé sur l'intégralité de la position de 9,94 millions d'actions. Les personnes déclarantes ne détiennent aucune autorité exclusive de vote ou de disposition, soulignant l'intention passive du dépôt. Chaque entité certifie que les titres n'ont pas été acquis dans le but d'influencer le contrôle, conformément aux exigences du Schedule 13G.

Cette divulgation fait d'OCI – un producteur mondial basé aux Pays-Bas de produits à base d'azote, de méthanol et d'hydrogène – l'un des plus grands actionnaires connus de Methanex. Bien que le dépôt n'annonce aucune condition de transaction ni plan stratégique, l'ampleur de la participation (d'une valeur d'environ 450 à 500 millions de dollars américains aux prix récents) témoigne de la confiance institutionnelle dans les perspectives du marché du méthanol de Methanex et pourrait présager une future collaboration ou activité d'entreprise au sein de la chaîne de valeur mondiale du méthanol.

OCI N.V. und seine niederländischen Tochtergesellschaften OCI Intermediate B.V. und OCI Chemicals B.V. haben ein Schedule 13G eingereicht, das eine beträchtliche passive Beteiligung an der Methanex Corporation (NASDAQ/TSX: MEOH) offenlegt. Die Meldung, ausgelöst durch ein Ereignis am 27. Juni 2025, zeigt eine wirtschaftliche Eigentümerschaft von 9.944.308 Stammaktien, was 12,9 % der 77.339.520 ausstehenden Methanex-Aktien zum 30. Juni 2025 entspricht.

Alle Aktien werden mit gemeinsamem Stimmrecht über 7.726.218 Aktien gehalten – unter der Auflage, nicht mehr als 9,99 % der ausstehenden Aktien des Unternehmens zu stimmen, bis die Bedingungen für die Notierung an der Toronto Stock Exchange erfüllt sind – und mit gemeinsamem Verfügungsrecht über die gesamte Position von 9,94 Millionen Aktien. Die meldenden Personen besitzen keine alleinige Stimm- oder Verfügungsbefugnis, was die passive Absicht der Meldung unterstreicht. Jede Einheit bestätigt, dass die Wertpapiere nicht zum Zweck der Einflussnahme auf die Kontrolle erworben wurden, gemäß den Anforderungen des Schedule 13G.

Die Offenlegung macht OCI – einen globalen Produzenten von Stickstoff-, Methanol- und Wasserstoffprodukten mit Sitz in den Niederlanden – zu einem der größten bekannten Aktionäre von Methanex. Obwohl die Meldung keine Transaktionsbedingungen oder strategischen Pläne bekannt gibt, signalisiert der Umfang der Beteiligung (im Wert von etwa 450-500 Millionen US-Dollar zu den jüngsten Kursen) institutionelles Vertrauen in die Methanolmarktprognosen von Methanex und könnte auf zukünftige Kooperationen oder Unternehmensaktivitäten innerhalb der globalen Methanol-Wertschöpfungskette hinweisen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hilado Maria Teresa

(Last) (First) (Middle)
345 E. MAIN STREET

(Street)
WARSAW IN 46580

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ZIMMER BIOMET HOLDINGS, INC. [ ZBH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Phantom Stock Units(1) $91.11(2) 06/30/2025 A 370.431 (3) (3) Common Stock 370.431 $0 10,505.352 D
Explanation of Responses:
1. The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
2. The Conversion or Exercise Price of Derivative Security is 1-for-1.
3. Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.
/s/ Matthew R. St. Louis, Attorney-in-Fact for Maria Teresa Hilado (power of attorney previously filed) 07/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Methanex (MEOH) shares does OCI now own?

OCI and its subsidiaries report beneficial ownership of 9,944,308 common shares.

What percentage of Methanex’s outstanding stock does the OCI stake represent?

The filing states the stake equals 12.9 % of the 77,339,520 shares outstanding as of June 30 2025.

Does OCI have full voting control over its Methanex shares?

No. OCI reports shared voting power on 7,726,218 shares and has agreed not to vote more than 9.99 % of the total outstanding shares.

Is OCI seeking to take control of Methanex?

The Schedule 13G certification affirms the stake is passive; OCI states it did not acquire the shares to influence control.

When was the ownership threshold that triggered this Schedule 13G crossed?

The event date requiring the filing is June 27 2025.

Could OCI’s investment lead to future strategic actions?

While the filing is passive, the industry overlap means investors should watch for any future Schedule 13D or partnership announcements.
Zimmer Biomet

NYSE:ZBH

ZBH Rankings

ZBH Latest News

ZBH Latest SEC Filings

ZBH Stock Data

18.10B
197.53M
0.2%
93.68%
3.54%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
WARSAW